Gival bleeding animal model with chronic periodontitis with blood coagulation disorder, method and application
Through thread ligation and drug injection, an animal model of gingival bleeding with chronic periodontitis and coagulation disorder was constructed, which solved the problem of lack of such models in the prior art, and realized gingival bleeding simulation in the case of coagulation disorder, supporting subsequent Research and new drug development.
Patent Information
- Application Number
- CN202411006897.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-12
AI Technical Summary
The lack of effective animal models in the prior art to simulate the gingival bleeding under chronic periodontitis with coagulation disorders, which leads to difficulties in research and development of new drugs, especially the inability to clarify the mechanism of action between the degree of coagulation disorders and gingival bleeding.
By performing wire ligation, endotoxin injection of Porphyromonas gingivalis and warfarin sodium gavage, an animal model of gingival bleeding with chronic periodontitis and coagulation disorder is constructed to ensure acute gingival bleeding in the case of coagulation disorders. and maintain a healthy state under other functional conditions.
An animal model of chronic periodontitis with coagulation disorder with gingival bleeding was successfully constructed except for coagulation disorders, filling the research gap, providing important reference for basic research and new drug research and development, and the model construction time is short, stable and reliable.
Smart Images

Figure CN118924473A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an animal model, method and application of gingival bleeding caused by chronic periodontitis with coagulation disorder, and belongs to the technical field of biological experimental model construction. Background Art
[0002] Chronic periodontitis is the most common type of periodontitis characterized by the destruction of periodontal tissues, accounting for about 95% of periodontitis patients. Periodontal pocket formation is one of the most important characteristics of periodontitis. The periodontal pocket contains plaque, tartar, gingival crevicular fluid, white blood cells, etc., which makes the soft tissue of the pocket wall often in a state of chronic inflammation. When the soft tissue of the pocket wall is mechanically stimulated by the outside world, it will cause bleeding in the pocket. Gingival bleeding is one of the common complications of periodontitis and can reflect the degree of periodontal tissue destruction. When continuous bleeding occurs, it indicates that the periodontal tissue is in an acute inflammatory state, and when the bleeding decreases, it indicates that the periodontal inflammation has entered a dormant state. However, not all chronic periodontitis is accompanied by gingival bleeding. In some cases, only red and swollen gums appear but no continuous bleeding is seen. The factors that cause gingival bleeding are quite complex. Common local irritants include tartar, external hard objects, etc. In addition, some special systemic conditions may promote gingival bleeding in the periodontitis state, such as systemic coagulation disorders.
[0003] Coagulation disorder is a common disease that is associated with oral or intravenous anticoagulants. Oral or intravenous anticoagulants are mainly used to prevent and treat the occurrence of thromboembolism. Bleeding is a common complication, such as cerebral hemorrhage, gingival bleeding, wound bleeding, etc. When patients with coagulation disorders have periodontitis, they are more likely to induce gingival bleeding, which shows that coagulation disorders are an important risk factor for gingival bleeding. When coexisting with periodontitis, they may be positively correlated with the incidence of gingival bleeding.
[0004] However, not all coagulation disorders will cause gingival bleeding. Based on the different dosages and metabolism of oral or intravenous anticoagulants in all patients, and the different circumstances in which they come to the hospital for treatment due to oral bleeding, epidemiological surveys can be used to infer that gingival bleeding in patients with systemic coagulation disorders under chronic periodontitis will be more biased. In addition, it must be pointed out that there is currently no basic research on the degree of coagulation disorders and gingival bleeding in chronic periodontitis, and the mechanism of action between the two is also unclear.
[0005] Therefore, constructing an animal model of acute gingival bleeding that can simulate chronic periodontitis accompanied by systemic coagulation disorders will be of great clinical significance for exploring the effects of periodontitis status and the degree of systemic coagulation disorders on gingival bleeding, as well as using this model for subsequent hemostatic material research. Summary of the invention
[0006] The present invention provides an animal model, method and application of gingival bleeding in chronic periodontitis with coagulation disorder. The animal model provided by the present invention can not only establish an obvious inflammatory state of gingival tissue in a relatively short period of time, but also ensure that the animal shows symptoms of acute gingival bleeding when other functions except coagulation disorder are intact, effectively filling the gap of the lack of animal models in the research field related to chronic periodontitis and coagulation disorder, and providing an important reference for basic research and new drug development based on this model.
[0007] To achieve this object, the present invention provides the following technical solutions:
[0008] The first aspect of the present invention provides a method for establishing an animal model of gingival bleeding caused by chronic periodontitis with coagulopathy, comprising the following steps:
[0009] S1. The first molar of the experimental animal was ligated with a wire, and the gingival sulcus was injected with Porphyromonas gingivalis endotoxin, which was recorded as the first day. For the next 28 days, Porphyromonas gingivalis endotoxin was injected twice every 7 days.
[0010] S2. On the 23rd to 25th day, the experimental animals were gavaged with warfarin sodium at a dose of 0.3-0.9 mg / kg of the experimental animal's body weight for 3-5 consecutive days. On the 28th day, the experimental animals were anesthetized at a dose of 0.3-0.9 mg / kg of the experimental animal's body weight, and orbital venous blood was obtained from the experimental animals to measure the coagulation time;
[0011] S3. Construct gingival wounds and establish an animal model of gingival bleeding in chronic periodontitis with coagulation disorder.
[0012] In the present invention, the difficulty of the invention lies in that the experimental animals are in an unhealthy state (periodontitis, low immunity) to construct a coagulation disorder, and the established coagulation disorder experimental animals need to survive under the conditions of open wounds and gingival bleeding for later experimental research.
[0013] In the present invention, the injection of Porphyromonas gingivalis endotoxin is of great significance when constructing periodontitis mice. The inventors of the present application have found through experiments that if Porphyromonas gingivalis endotoxin is not injected, the periodontitis wound of mice is small, and when an open wound is performed later to cause gingival bleeding, the open wound that needs to be constructed is larger, and systemic infection is prone to occur in the state of coagulation disorder, thereby leading to the death of experimental animals.
[0014] In the present invention, the use time and dosage of warfarin sodium are particularly important. If warfarin sodium is used excessively, the experimental animals will die soon. If warfarin sodium is used too little, the coagulation disorder of the experimental animals will not be successfully established. The inventors of the present application have screened the dosage of warfarin sodium through a large number of experiments. In order to cooperate with the time period of periodontitis establishment. The experimental animals are established as soon as possible so that they can be put into subsequent experimental research during the survival period of the experimental animals. The inventors of the present application have found that the best administration time is to gavage warfarin sodium on the 23rd to 25th day for 3-5 consecutive days until the 28th day.
[0015] Preferably, the method of performing wire ligation on the first molar in step S1 comprises the following steps:
[0016] S11. Anesthetize and fix the experimental animal, expose the molars with an opener, clean the molars and buccal and lingual gums, and dry with cotton balls;
[0017] S12, remove the needle from the surgical 3-0 suture, use the micro needle holder to hold the silk thread, pass the silk thread through the interdental space between the first molar and the second molar, and wrap around the first molar;
[0018] S13, use the micro needle holder to tie a knot on the palatal side of the first molar, and cut off the excess ligature with scissors;
[0019] S14, cut off a 0.2 mm portion of the orthodontic ligature wire, pass the ligature wire through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0020] S15. Use the micro needle holder to tie a knot on the palatal side of the first molar, press the ligature on top of the silk thread, and cut off the excess ligature with scissors.
[0021] Preferably, step S3 comprises the following steps:
[0022] S31, remove the sutures and orthodontic ligatures, and use saline cotton balls to clean the palatal tooth surface and gums;
[0023] S32. Use a pointed probe to reach into the periodontal pocket on the palatal side and repeatedly damage the gums, causing bleeding gums.
[0024] Preferably, in step S1, the injection dose of Porphyromonas gingivalis endotoxin is 0.1 mL and the concentration is 0.1 mg / mL.
[0025] Preferably, in step S2, the dose of warfarin sodium is 0.4 mg / kg body weight of the experimental animal.
[0026] In the present invention, the research team used different concentrations of anticoagulants for oral administration to SD rats, aiming to select the most appropriate oral administration concentration, so as to induce coagulation disorder in the rats while ensuring that other vital signs of the rats were normal, and to facilitate the construction of a gingival bleeding model and maintain survival to meet the requirements of at least 1 week of follow-up research.
[0027] Preferably, the administration time of warfarin sodium is: starting from the 25th day, for 3 consecutive days.
[0028] Preferably, the animal is a rat. Further preferably, the rat is an 8-week-old SD male rat.
[0029] Preferably, the survival time of the animal model of gingival bleeding with chronic periodontitis and coagulopathy constructed in the present invention is not less than one week.
[0030] Preferably, the method for establishing an animal model of gingival bleeding due to chronic periodontitis and coagulopathy comprises the following steps:
[0031] Step R1: Establishment and maintenance of chronic periodontitis model
[0032] Step R11: The rats were anesthetized and fixed, the right maxillary molars were exposed using an opener, the maxillary right first molars and buccal and lingual gums were cleaned, and dried with cotton balls;
[0033] Step R12: Remove the needle from the surgical 3-0 suture, use the micro needle holder to hold the silk thread, pass the silk thread through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0034] Step R13: Use the micro needle holder to tie a knot on the palatal side of the upper right first molar, and cut off the excess ligature with scissors;
[0035] Step R14: Cut off a portion of 0.2 mm of orthodontic ligature wire, pass the ligature wire through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0036] Step R15: Use the micro needle holder to tie a knot on the palatal side of the upper right first molar, press the ligature on top of the silk thread, and cut off the excess ligature with scissors;
[0037] Step R16: injecting Porphyromonas gingivalis endotoxin into the lingual gingival sulcus of the upper right first molar of the rat, with an injection dose of 0.1 mL and a stock solution concentration of 0.1 mg / mL;
[0038] Step R17: In the following four weeks, Porphyromonas gingivalis endotoxin was injected twice a week, with each injection dose being 0.1 mL.
[0039] Step R2: Construction of coagulopathy rats
[0040] Step R21: Use a 1 mL syringe to extract a certain amount of pre-prepared warfarin sodium stock solution for standby use, and then weigh the rats to be gavaged;
[0041] Step R22: Gently grab the weighed rat and fix its head, and use a curved gavage needle to perform intraperitoneal gavage at a dose of 0.4 mL / kg body weight;
[0042] Step R23: Repeat steps S21 and S22 at a fixed gavage frequency every day for 3 consecutive days;
[0043] Step R3: Establishment of an animal model of gingival bleeding in rats with chronic periodontitis aggravated by coagulation disorder
[0044] Step R31: Repeat all the operations in R1 to establish a rat chronic periodontitis model.
[0045] Step R32: Repeat all the operations in R2 on day 25 to establish a rat coagulation disorder model.
[0046] Step R33: On the 28th day, the rats were anesthetized and blood was collected from their orbits, and the prothrombin time was tested to determine whether the coagulation disorder model was successful.
[0047] Step R34: After the rat coagulation disorder model was successfully established, a sharp probe was inserted into the periodontal pocket on the palatal side of the rat's upper right first molar to destroy the gingival tissue back and forth to create a bleeding wound.
[0048] The second aspect of the present invention provides an animal model of gingival bleeding caused by chronic periodontitis with coagulation disorder established by the method described in the present invention.
[0049] Preferably, the method for establishing an animal model of gingival bleeding due to chronic periodontitis and coagulopathy comprises the following steps:
[0050] S1. The first molar of the experimental animal was ligated with a wire, and the gingival sulcus was injected with Porphyromonas gingivalis endotoxin, which was recorded as the first day. For the next 28 days, Porphyromonas gingivalis endotoxin was injected twice every 7 days.
[0051] S2. On the 23rd to 25th day, the experimental animals were gavaged with warfarin sodium for 3-5 consecutive days. On the 28th day, the experimental animals were anesthetized and orbital venous blood was obtained to measure the coagulation time.
[0052] S3. Construct gingival wounds and establish an animal model of gingival bleeding in chronic periodontitis with coagulation disorder.
[0053] Preferably, the method of performing wire ligation on the first molar in step S1 comprises the following steps:
[0054] S11. Anesthetize and fix the experimental animal, expose the molars with an opener, clean the molars and buccal and lingual gums, and dry with cotton balls;
[0055] S12, remove the needle from the surgical 3-0 suture, use the micro needle holder to hold the silk thread, pass the silk thread through the interdental space between the first molar and the second molar, and wrap around the first molar;
[0056] S13, use the micro needle holder to tie a knot on the palatal side of the first molar, and cut off the excess ligature with scissors;
[0057] S14, cut off a 0.2 mm portion of the orthodontic ligature wire, pass the ligature wire through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0058] S15. Use the micro needle holder to tie a knot on the palatal side of the first molar, press the ligature on top of the silk thread, and cut off the excess ligature with scissors.
[0059] Preferably, step S3 comprises the following steps:
[0060] S31, remove the sutures and orthodontic ligatures, and use saline cotton balls to clean the palatal tooth surface and gums;
[0061] S32. Use a pointed probe to reach into the periodontal pocket on the palatal side and repeatedly damage the gums, causing bleeding gums.
[0062] Preferably, in step S1, the injection dose of Porphyromonas gingivalis endotoxin is 0.1 mL and the concentration is 0.1 mg / mL.
[0063] Preferably, in step S2, the dosage of warfarin sodium is 0.4 mg / kg body weight.
[0064] Preferably, the administration time of warfarin sodium is: starting from the 25th day, for 3 consecutive days.
[0065] Preferably, after administration, the rats with coagulation disorders need to be kept in separate cages to prevent the rats from attacking each other due to mixed breeding, thereby accelerating the death of the rats.
[0066] Preferably, the animal is a rat.
[0067] The third aspect of the present invention provides the use of the animal model of gingival bleeding caused by chronic periodontitis with coagulopathy established by the method of the present invention in the research of hemostatic materials or drugs.
[0068] The fourth aspect of the present invention provides the use of the animal model of gingival bleeding with chronic periodontitis and coagulopathy established by the method of the present invention in a study on the effects of periodontitis status and the degree of systemic coagulopathy on gingival bleeding.
[0069] In summary, the establishment of an acute gingival bleeding model in experimental animals with coagulation disorders under chronic periodontitis is not just a simple superposition of a chronic periodontitis model and a coagulation disorder model. How to promote gingival bleeding in experimental animals with chronic periodontitis on the basis of maintaining coagulation disorders is a difficult issue. The time point of coagulation disorder construction and the time point of wound creation will have unpredictable effects on the construction of an acute gingival bleeding model in experimental animals with coagulation disorders under chronic periodontitis.
[0070] Compared with the prior art, the beneficial effects and significant improvements of the technical solution of the present invention are:
[0071] 1. The present invention effectively fills the gap of the lack of an animal model of acute gingival bleeding in experimental animals with coagulation disorders under chronic periodontitis. It is the first innovative simulation of an acute gingival bleeding model of experimental animals with chronic periodontitis whose other vital signs are stable except for coagulation abnormalities. It provides great application value for the subsequent screening of new gingival hemostatic drugs and broadens the research ideas and methods in this field to a certain extent.
[0072] 2. The present invention simulates the acute gingival bleeding animal model of coagulation disorder experimental animals under chronic periodontitis state, which takes a total of 28 days. That is, the coagulation disorder model is constructed while the chronic periodontitis model is constructed, and the construction time is not extended. The modeling effect is stable and reliable, and the modeling time is short.
[0073] 3. Based on the establishment of a chronic periodontitis model using silk thread ligation and intragingival sulcus injection of Porphyromonas gingivalis endotoxin, the experimental animals were gavaged with warfarin sodium on the 23rd to 25th day, thereby ensuring the stability of the basic vital signs of the experimental animals and reducing the impact of warfarin sodium metabolism on subsequent experiments. The modeling sequence is scientific to a certain extent;
[0074] 4. In the present invention, the experimental animals are gavaged with warfarin sodium at a dose of 0.3-0.9 mg / kg body weight for 3 consecutive days, which can maintain the coagulation disorder state without causing the death of the experimental animals. This is a reasonable dosage and time. BRIEF DESCRIPTION OF THE DRAWINGS
[0075] In order to more clearly illustrate the technical solution of the present invention, the drawings used in the embodiments of the present invention are briefly introduced below.
[0076] Figure 1 is a modeling flow chart of Example 3;
[0077] Figure 2 is an operation schematic diagram of Embodiment 3;
[0078] Figure 3 is a three-dimensional reconstruction of the right maxillary bone in Example 3;
[0079] Figure 4 is the HE staining image of the left and right maxilla in Example 3;
[0080] Figure 5 This is a picture of gingival bleeding in the oral cavity of a rat in Example 3. DETAILED DESCRIPTION
[0081] To make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the present invention is further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental methods in the following examples that do not specify specific conditions are usually based on conventional conditions or the conditions recommended by the manufacturer. Unless otherwise specified, percentages and parts are weight percentages and weight parts. The experimental materials and reagents used in the following examples can be obtained from commercial channels unless otherwise specified.
[0082] Unless otherwise specified, the technical and scientific terms used herein have the same meaning as commonly understood by ordinary technicians in the technical field to which the application belongs. It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments of the present application.
[0083] In order to more fully understand the present invention, the professional terms in the present invention are explained below.
[0084] Porphyromonas gingivalis endotoxin is an endotoxin produced by Porphyromonas gingivalis, a Gram-negative anaerobic coccobacillus that is a non-fermenting saccharolytic bacillus and is one of the important periodontal pathogens that has been widely studied and has sufficient evidence.
[0085] Warfarin sodium, also known as phenylacetone coumarin, has the effect of competitively inhibiting vitamin K. Vitamin K epoxide is converted into a hydroquinone structure in the body, participating in the synthesis of prothrombin (coagulation factor II), and inhibiting the γ-carboxylation of the terminal glutamic acid residues of coagulation factor VII, IX, and X proteins, resulting in the inactivation of the precursors of coagulation factors II, VII, IX, and X, thereby inhibiting the occurrence of blood coagulation process.
[0086] Injection refers to the use of medical devices such as syringes to inject liquid or gas into the human body for the purpose of diagnosing, treating, and preventing diseases. It is different from taking medicine. After injection, the medicine can quickly reach the blood and take effect.
[0087] Example 1 Establishment and maintenance of chronic periodontitis model
[0088] Group 1 (first molar ligature)
[0089] 1.1. Anesthetize and fix the rats, expose the right maxillary molars with an open mouth, clean the maxillary right first molars and buccal and lingual gums, and dry with cotton balls;
[0090] 1.2. Remove the needle from the surgical 3-0 suture, use the micro needle holder to hold the silk thread, pass the silk thread through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0091] 1.3. Use the micro needle holder to tie a knot on the palatal side of the upper right first molar, and cut off the excess ligature with scissors;
[0092] 1.4. Cut off a 0.2mm portion of the orthodontic ligature wire, pass the ligature wire through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0093] 1.5. Use the micro needle holder to tie a knot on the palatal side of the upper right first molar, press the ligature on top of the silk thread, and cut off the excess ligature with scissors.
[0094] Group 2 (first molar ligation + Porphyromonas gingivalis endotoxin injection)
[0095] 2.1. Anesthetize and fix the rats, use an opener to expose the right maxillary molars, clean the maxillary right first molars and buccal and lingual gums, and dry with cotton balls;
[0096] 2.2. Remove the needle from the surgical 3-0 suture, use the micro needle holder to hold the silk thread, pass the silk thread through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0097] 2.3. Use the micro needle holder to tie a knot on the palatal side of the upper right first molar and cut off the excess ligature with scissors;
[0098] 2.4. Cut off a 0.2mm portion of the orthodontic ligature wire, pass the ligature wire through the interdental space between the first molar and the second molar, and wrap around the upper right first molar;
[0099] 2.5. Use the micro needle holder to tie a knot on the palatal side of the upper right first molar, press the ligature on top of the silk thread, and cut off the excess ligature with scissors;
[0100] 2.6. Inject Porphyromonas gingivalis endotoxin into the lingual gingival sulcus of the upper right first molar of rats. The injection dose was 0.1 mL and the stock solution concentration was 0.1 mg / mL.
[0101] 2.7. In the following four weeks, Porphyromonas gingivalis endotoxin was injected twice a week, with each injection dose being 0.1 mL.
[0102] The periodontal conditions of the rats in Group 1 and Group 2 were observed after 28 days of cultivation. The wound surface of the first molar of the rats in Group 1 was basically healed, and the gums were light red. The wound surface of the first molar of the rats in Group 2 was obviously inflamed, and there were more obvious symptoms of red and swollen gums. The rats in Group 2 were more conducive to the construction of the animal model of gingival bleeding with chronic periodontitis and coagulation disorder of the present invention, because the rats in Group 2 were conducive to the construction of the bleeding wound surface in the later stage.
[0103] Example 2 Study on warfarin dosage
[0104] 1. Materials
[0105] Eight 7-week-old SD rats were provided by Shanghai Jihui Experimental Animal Breeding Co., Ltd. and were kept in the SPF environment of the Experimental Animal Center of Pudong Science and Education Park of the Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine. This experiment was approved by the Animal Ethics Committee of the Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine. 3-0 silk non-absorbable sutures were provided by Shanghai Pudong Jinhuan Medical Supplies Co., Ltd., 0.2 mm ligature wire was provided by Hangzhou Osuo Medical Instrument Co., Ltd., warfarin sodium was provided by MacLean Company, model 129-06-6, and Porphyromonas gingivalis endotoxin was provided by InvivoGen.
[0106] 2. Reagent Preparation
[0107] Porphyromonas gingivalis endotoxin (concentration 100 μg / mL): Porphyromonas gingivalis endotoxin (1 mg) + PBS (10 mL)
[0108] Warfarin Sodium
[0109] 3. Experimental Grouping
[0110] Group A: The right maxillary first molar was ligated and warfarin sodium was administered orally for 3 consecutive days at a concentration of 0.1 mg / kg body weight.
[0111] Group B: The right maxillary first molar was ligated and warfarin sodium was administered orally for 3 consecutive days at a concentration of 0.2 mg / kg body weight.
[0112] Group C: The right maxillary first molar was ligated and warfarin sodium was administered orally for 3 consecutive days at a concentration of 0.4 mg / kg body weight.
[0113] Group D: The right maxillary first molar was ligated and warfarin sodium was administered orally for 3 consecutive days at a concentration of 1 mg / kg body weight.
[0114] Group E: The right maxillary first molar was ligated and warfarin sodium was administered orally for 3 consecutive days at a concentration of 1.5 mg / kg body weight.
[0115] Group F: The right maxillary first molar was ligated and warfarin sodium was administered orally at a concentration of 2 mg / kg body weight for 3 consecutive days.
[0116] IV. Experimental methods and procedures
[0117] (1) Male SPF SD rats were transported to the Experimental Animal Center of Pudong Science and Education Park, the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and were adaptively raised in the animal center with a temperature of 20-24°C, a relative humidity of 30-70%, a light rhythm of 12D, 12L, a working illumination of ≥150lx, and an airflow of ≤0.2m / s.
[0118] (2) Rats were randomly divided into AF groups, with 1-2 rats in each group.
[0119] (3) On the first day, all six groups of rats were ligated with 3-0 silk thread and fixed with 0.22mm orthodontic ligature with a micro needle holder. If the silk thread fell off, it was necessary to re-ligate and keep records. After intraperitoneal anesthesia, the rats were fixed on the operating table, and an opener was used to ensure that the rats opened their mouths stably. The right maxillary molar area was exposed, and the buccal and lingual gums of the right maxillary molar were cleaned and dried thoroughly. The needle on the 3-0 silk thread was removed, and the micro needle holder was used to insert it into the lower part of the adjacent point of the right maxillary first and second molars in a dental floss-like manner, and the tooth surface was wrapped around the narrowed area of the neck of the first molar on the labial and buccal sides. The needle holder was used to tie a knot on the palatal side of the first molar, and similarly, a 0.22mm ligature was used for fixation. A 1mL syringe was used to absorb the diluted Porphyromonas gingivalis endotoxin, and 100μL was injected into the palatal gingival sulcus.
[0120] 25 days after the establishment of the periodontitis model, the six groups of rats were fixed by hand and intraperitoneally administered with warfarin sodium using an intragastric needle. This was continued for 3 consecutive days. After 3 days, all rats were intraperitoneally anesthetized, and blood was collected from the orbital vein using a capillary blood collection tube. The prothrombin time of the rats was measured to determine whether the coagulation disorder model was successfully established.
[0121] V. Experimental Results
[0122] The results of the prothrombin time test showed that the PT value of rats in the 2mg / kg group was 174.1s, the 1.5mg / kg group exceeded the upper limit of the instrument and could not be detected, and the PT value of the 1mg / kg group was 176.3s, which was much higher than the PT value of normal rats. All rats in these three groups died immediately or within one day after blood was drawn. In addition, when warfarin at a concentration of 0.1mg / kg and 0.2mg / kg body weight was administered intragastrically, the PT was found to be 9.8-11.7s. Compared with the normal group (control group), the INR was less than 2, which did not meet the modeling conditions. The prothrombin time of rats in the 0.4mg / kg body weight warfarin group was significantly prolonged, and INR>2, indicating that the coagulation disorder rat model was successfully constructed.
[0123] In summary, the model established by oral administration of warfarin at a concentration of 0.4 mg / kg body weight can not only stably produce bleeding wounds, but also maintain the vital signs of rats, ensuring the subsequent progress of the experiment, and filling the gap in the lack of a gingival bleeding model in the rat oral cavity.
[0124] Example 3
[0125] The experimental materials and reagents were the same as those in Example 2. Figure 1 and 2 As shown, Figure 1 This is the operating mode diagram of the experiment. First, a chronic periodontitis model was established, then a coagulation disorder model was established, and finally a gingival bleeding model was established. All rats were killed after 35 days. Figure 2 Schematic diagram of the experimental operation.
[0126] 1. Experimental Grouping
[0127] Control group (Group G): Normal coagulation group, the right maxillary first molar was ligated, and no warfarin sodium was gavaged.
[0128] Experimental group (H group): coagulation disorder group, the right maxillary first molar was ligated and warfarin sodium was continuously gavaged for 3 days.
[0129] 2. Experimental methods and procedures
[0130] (1) Thirty-six male SPF SD rats were transported to the Experimental Animal Center of Pudong Science and Education Park, the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and were adaptively raised in the animal center with a temperature of 20-24°C, a relative humidity of 30-70%, a light rhythm of 12D, 12L, a working illumination of ≥150lx, and an airflow of ≤0.2m / s.
[0131] (2) Thirty-six rats were randomly divided into group G and group H, with 18 rats in each group.
[0132] (3) On the first day, both groups of rats were ligated with 3-0 silk thread and fixed with 0.22mm orthodontic ligature with a micro needle holder. If the silk thread fell off, it was necessary to re-ligate and keep records. After intraperitoneal anesthesia, the rat was fixed on the operating table, and an opener was used to ensure that the rat opened its mouth stably, exposing the right maxillary molar area, cleaning the buccal and lingual gingiva of the right maxillary molar, and drying it thoroughly. The needle on the 3-0 silk thread was removed, and the micro needle holder was used to insert it into the lower part of the adjacent point of the first and second maxillary right molars in a dental floss-like manner, and the tooth surface was wrapped around the narrowed area of the neck of the first molar on the labial and buccal sides. The needle holder was used to tie a knot on the palatal side of the first molar, and similarly, a 0.22mm ligature was used for fixation. A 1mL syringe was used to absorb the diluted Porphyromonas gingivalis endotoxin, and 100μL was injected into the palatal gingival sulcus.
[0133] 25 days after the establishment of the periodontitis model, the H rats were fixed by hand and intraperitoneally administered with warfarin sodium using a gavage needle at a concentration of 0.4 mg / kg body weight for 3 consecutive days. After 3 days, all rats were intraperitoneally anesthetized, and blood was collected from the orbital vein using a capillary blood collection tube, and the prothrombin time of the rats was measured to determine whether the coagulation disorder model was successfully established.
[0134] After the rat coagulation disorder model was successfully established, the silk thread and ligature were removed, and a sharp probe was inserted into the palatal periodontal pocket of the rat's upper right first molar to destroy the gingival tissue back and forth to create a bleeding wound.
[0135] (4) Once the bleeding model is successfully established, it will be used to verify the effectiveness of the hemostatic material. After the experiment, the mice were euthanized, and the soft and hard tissues of the maxillary bones were sampled and HE staining was used to examine the inflammation.
[0136] 3. Experimental Results
[0137] The three-dimensional reconstruction diagram of the experimental rats after micro-CT scanning of the jaws at the end of the experiment is shown in the figure below. Figure 3 As shown, the results showed that the alveolar bone of the right maxillary first molar of SD rats was significantly resorbed.
[0138] G and H. HE staining of maxillary bone sections of rats at the end of the experiment. Figure 4 As shown, a and c are the left maxillary first molar sections of the control group G and the experimental group H, respectively, b and d are the right maxillary first molar sections of the control group G and the experimental group H, respectively. The results showed that obvious alveolar bone absorption and inflammatory destruction of periodontal tissues were observed on the binding wire side (right maxillary first molar) of both the control group G and the experimental group H, indicating that the ligature-induced chronic periodontitis model was successfully established.
[0139] Photos of gingival bleeding in the mouth of rats G and H Figure 5 As shown, the results showed that this method can successfully establish an intraoral gingival bleeding model.
[0140] The prothrombin time of G and H rats is shown in Table 1. The results showed that the prothrombin time of rats in the experimental group H was significantly prolonged, and INR>2, indicating that the coagulation disorder rat model was successfully established.
[0141] Table 1
[0142]
[0143] The applicant declares that, in the description of the above specification:
[0144] The descriptions of the terms "this embodiment", "an embodiment of the present invention", "as shown in...", "further", "a further improved technical sub-scheme", etc., mean that the specific features, structures, materials or characteristics described in the embodiment or example are included in at least one embodiment or example of the present invention; in this specification, the schematic expressions of the above terms are not necessarily for the same embodiment or example, and the specific features, structures, materials or characteristics described may be combined or combined in a suitable manner in any one or more embodiments or examples; in addition, a person of ordinary skill in the art may combine or combine the different embodiments or examples and the features of the different embodiments or examples described in this specification without causing any contradiction.
[0145] Finally, it should be noted that:
[0146] The above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them.
[0147] Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some or all of the technical features therein, and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments of the present invention. The non-essential improvements, adjustments or replacements made by those skilled in the art based on the contents of this specification are all within the scope of protection required by the present invention.
Claims
1. Method for establishing an animal model of gingival bleeding in chronic periodontitis with coagulation disorder. It is characterized in that The following steps are involved: S1. The first molar of the experimental animal was ligated with a wire, and the gingival sulcus was injected with Porphyromonas gingivalis endotoxin, which was recorded as the first day. For the next 28 days, Porphyromonas gingivalis endotoxin was injected twice every 7 days. S2. On the 23rd to 25th day, the experimental animals were gavaged with warfarin sodium at a dose of 0.3-0.9 mg / kg of the experimental animal's body weight for 3-5 consecutive days. On the 28th day, the experimental animals were anesthetized and orbital venous blood was obtained to measure the coagulation time. S3. Construct gingival wounds and establish an animal model of gingival bleeding in chronic periodontitis with coagulation disorder.
2. The method according to claim 1, It is characterized in that The method for performing ligature ligation on the first molar in step S1 comprises the following steps: S11. Anesthetize and fix the experimental animal, expose the molars with an opener, clean the molars and buccal and lingual gums, and dry with cotton balls; S12, remove the needle from the surgical 3-0 suture, use the micro needle holder to hold the silk thread, pass the silk thread through the interdental space between the first molar and the second molar, and wrap around the first molar; S13, use the micro needle holder to tie a knot on the palatal side of the first molar, and cut off the excess ligature with scissors; S14, cut off a 0.2 mm portion of the orthodontic ligature wire, pass the ligature wire through the interdental space between the first molar and the second molar, and wrap around the upper right first molar; S15. Use the micro needle holder to tie a knot on the palatal side of the first molar, press the ligature on top of the silk thread, and cut off the excess ligature with scissors.
3. The method according to claim 2, It is characterized in that Step S3 includes the following steps: S31, remove the sutures and orthodontic ligatures, and use saline cotton balls to clean the palatal tooth surface and gums; S32. Use a pointed probe to reach into the periodontal pocket on the palatal side and repeatedly damage the gums, causing bleeding gums.
4. The method according to claim 1, It is characterized in that In step S1, the injection dose of Porphyromonas gingivalis endotoxin is 0.1 mL, and the concentration is 0.1 mg / mL.
5. The method according to claim 1, It is characterized in that In step S2, the dose of warfarin sodium is 0.4 mg / kg body weight of the experimental animal.
6. The method according to claim 1, It is characterized in that The administration schedule of warfarin sodium is: starting from the 25th day, for 3 consecutive days.
7. The method according to claim 1, It is characterized in that The animals are rats.
8. An animal model of gingival bleeding caused by chronic periodontitis and coagulopathy established by the method according to any one of claims 1 to 7.
9. Use of the animal model of gingival bleeding caused by chronic periodontitis and coagulopathy established by the method according to any one of claims 1 to 7 in the research of hemostatic materials or drugs.
10. Use of the animal model of gingival bleeding with chronic periodontitis and coagulopathy established by the method described in any one of claims 1 to 7 in a study on the effects of periodontitis status and the degree of systemic coagulopathy on gingival bleeding.
Citation Information
Cited By
Construction method and application of stomach fire flaming type chronic periodontitis animal model
CN119423009A
Method for creating experimental model of chronic periodontitis in laboratory rats
RU2864234C1
Method for constructing periodontitis rat model and use thereof
WO2026144312A1
